IBT
AVDL

International Biotechnology Trust’s Avadel Pharmaceuticals AVDL Stock Holding History

International Biotechnology Trust’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-122
Closed -$50K – 70
2022
Q2 		$50K Sell
122
-49,878
-100% -$205K 0.52% 43
2022
Q1 		$7.65M Buy
+50,000
New +$344K 1.72% 22

Other funds holding AVDL

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.05% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return

International Biotechnology Trust's AVDL Position: Q3 2022 in Review

International Biotechnology Trust sold out of Avadel Pharmaceuticals (AVDL) in Q3 2022, closing a stake of 122 shares — an estimated $50K sold.

International Biotechnology Trust first reported a position in AVDL in Q1 2022 and held it in 2 quarters. The position peaked at $7.65M in Q1 2022. 76 funds tracked by Wall St. Rank hold AVDL as of Q3 2022.

  • International Biotechnology Trust reported no remaining Avadel Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 122 Avadel Pharmaceuticals shares in Q3 2022, an estimated $50K.
  • International Biotechnology Trust first reported a position in Avadel Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • International Biotechnology Trust's Avadel Pharmaceuticals position peaked at $7.65M in Q1 2022.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2022.

Based on International Biotechnology Trust's 13F filing for Q3 2022, filed 8 Nov 2022.